钠和氯稳态紊乱可预测稳定期和危重症肝硬化患者的结局
研究纳入891例晚期慢性肝病(ACLD)患者和181例ICU肝硬化患者,评估基线低钠/高钠血症和低氯/高氯血症与结局的关系。ACLD队列中,较低血清氯与肝失代偿/肝相关死亡显著相关(校正平均HR 0.965,95%CI 0.945-0.986,p=0.001),低氯血症亦显著相关(校正平均HR 1.656,95%CI 1.267-2.163,p<0.001)。ICU队列中,低氯血症与ICU死亡独立相关(aOR 3.200,95%CI 1.209-8.829,p=0.021)。
要点
- ACLD队列中,较低血清氯与肝失代偿/肝相关死亡显著相关(校正平均HR 0.965,95%CI 0.945-0.986)。
- ACLD队列中,低氯血症与肝失代偿/肝相关死亡显著相关(校正平均HR 1.656,95%CI 1.267-2.163)。
- ICU队列中,低氯血症与ICU死亡独立相关(aOR 3.200,95%CI 1.209-8.829,p=0.021)。
核心结论
- 低氯血症与临床稳定和危重症肝硬化患者的死亡率增加相关,且独立于包括血清钠在内的MELD。
研究设计与样本
- ACLD队列:891例晚期慢性肝病(HVPG≥6 mm Hg)患者,2003至2020年间HVPG测量后随访。
- ICU队列:181例2004至2007年入住ICU的危重症肝硬化患者。
- 评估基线低钠/高钠血症(正常136-145 mmol/L)和低氯/高氯血症(正常98-107 mmol/L)。
主要发现
- ACLD队列:68%为男性,中位MELD(经Na校正)11(9-17),Child-Pugh分期A/B/C为46%/38%/16%,中位随访60个月。
- ACLD队列:较低血清氯与肝失代偿/肝相关死亡显著相关(校正平均HR每mmol/L 0.965,95%CI 0.945-0.986,p=0.001)。
- ACLD队列:低氯血症与肝失代偿/肝相关死亡显著相关(校正平均HR 1.656,95%CI 1.267-2.163,p<0.001)。
- ICU队列:70%为男性,入ICU时中位MELD 31(22-39),92%为Child-Pugh C级。
- ICU队列:校正低钠/高钠血症、MELD和血pH后,低氯血症仍与ICU死亡独立相关(aOR 3.200,95%CI 1.209-8.829,p=0.021)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hyponatremia has prognostic implications in patients with cirrhosis, and thus, has been incorporated in the 2016 MELD-UNOS update. Changes in serum chloride are commonly perceived as 'just' parallel to changes in serum sodium. However, these are less well studied in the context of cirrhosis. AIMS: To investigate whether serum chloride independently predicts outcomes in patients with advanced chronic liver disease (ACLD) and stable clinical course or with critical illness. METHODS: 891 patients with ACLD (defined by hepatic venous pressure gradient [HVPG] ≥6 mm Hg) were followed after HVPG measurement between 2003 and 2020 (ACLD cohort). 181 critically ill patients with cirrhosis admitted to the ICU between 2004 and 2007 were recruited for the ICU cohort. Hypo-/hypernatremia (normal: 136-145 mmol/L) and hypo-/hyperchloremia (normal: 98-107 mmol/L) at baseline were assessed. RESULTS: ACLD cohort: 68% of male patients with a median MELD (adjusted for Na) of 11 (9-17) were included (Child-Pugh-stages-A/B/C: 46%/38%/16%) and followed for a median of 60 months. Lower serum chloride (adjusted average HR per mmol/L: 0.965 [95% confidence interval (95% CI): 0.945-0.986], p = 0.001) showed a significant association with hepatic decompensation/liver-related mortality on multivariable Cox regression analysis adjusted for age, HVPG, albumin and MELD. In line, hypochloremia was significantly associated with hepatic decompensation/liver-related mortality (adjusted average HR: 1.656 [95% CI:1.267-2.163], p < 0.001). ICU cohort: 70% of patients were male, median MELD was 31(22-39) at ICU admission (92% with Child-Pugh-stage-C). After adjusting for hypo-/hypernatremia, MELD, and blood pH, hypochloremia remained independently associated with ICU-mortality (aOR Cl: 3.200 [95%CI: 1.209-8.829], p = 0.021). CONCLUSION: Hypochloremia is associated with increased mortality in clinically stable and critically ill patients with cirrhosis independently of MELD including serum sodium.
引用
- Semmler G, Scheiner B, Balcar L, et al. Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosis. Aliment Pharmacol Ther. 2023. PMID: 37016513. doi:10.1111/apt.17507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。